Article
- Author:
-
Jacques Donzé, MD, MSc
-
Stuart Lipsitz, SCD
-
Jeffrey L. Schnipper, MD, MPH
News
- Author:
-
Mara Antonoff, MD
-
Sanford M. Zeigler, MD
Publish date: February 13, 2014
News
- Author:
-
Leigh Fredholm, MD
-
Stephen Bekanich, MD
Publish date: February 13, 2014
News
- Author:
-
Leslie S. Baumann, MD
Publish date: February 13, 2014
News
- Author:
-
HT Staff
Publish date: February 13, 2014
Credit: Rhoda Baer
The US Food and Drug Administration (FDA) has expanded the indication for the Bruton’s tyrosine kinase inhibitor ibrutinib (...
News
- Author:
-
HT Staff
Publish date: February 13, 2014
Researchers have linked a mutation causing Down syndrome-associated leukemias to developmental abnormalities in megakaryocytes.
Experiments...
News
- Author:
-
HT Staff
Publish date: February 13, 2014
Credit: George Hodan
Although they initially show signs of psychological distress, parents of children undergoing stem cell transplant (SCT) are...
News
- Author:
-
HT Staff
Publish date: February 13, 2014
These HSCs also appear to be a means of treatment resistance and may trigger relapse in patients with AML, investigators reported in Nature.
“Our...
Article
- Author:
-
Mark V. Williams, MD, FACP, MHM
Article
- Author:
-
S. Ryan Greysen, MD, MHS, MA
-
Raman R. Khanna, MD, MAS
-
Ronald Jacolbia, BA
-
Herman M. Lee, BA
-
Andrew D. Auerbach, MD, MPH
Pages